Type 2 & other diabetes

Quality of Diabetes Care Among Older Adults in Germany—Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys

Diabetes Obes MetabPublished Cross-sectional study

Authors' conclusion

In Germany, most older adults with diabetes meet targets of non-smoking, non-obesity and BP control. Use of novel glucose-lowering medications with cardiorenal benefits is low.

Study context

Population
People aged ≥66 years with diabetes, German national Study on Health of Older People (Gesundheit65+) 2022/2023; trends in subgroup aged 66–79 years
Participants
292 people
Outcome
Quality of diabetes care indicators: physical exercise, non-smoking, non-obesity, BP control, guideline-based use of statins, ACEI/ARB, GLP-1 RA/SGLT2i and aspirin
Methodological detailsnational health examination survey, trend analysis vs 1997–1999 and 2008–2010 surveys
  • National health examination survey
  • Trend analysis vs 1997–1999 and 2008–2010 surveys

Main finding

As reported in the abstract

Diabetes care indicators · 2022/2023
Non-smokers
90.6%
Non-obese
69.6%
Blood pressure (BP) control achieved
74.2%
Physical exercise
45.5%
Statin use (overall)
65.7%
ACEI/ARB use among those with hypertension
88.4%
GLP-1 RA/SGLT2i use among those with CVD
36.8%
Aspirin use among those with CVD
55.4%

Observational data: associations, not effects.

Further findings

Glucose-lowering medication use · 2022/2023

Any antidiabetics
73.6%
Mono-metformin therapy
24.3%
Insulin (alone or in combination)
16.9%
Other glucose-lowering medication
32.4%

Time trends, subgroup aged 66-79 years · 1997–1999, 2008–2010 to 2022/2023

Decrease in insulin use and improvements in physical exercise, non-obesity, BP control and guideline-based medications

Original publication

Quality of Diabetes Care Among Older Adults in Germany—Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys. Diabetes Obes Metab. Published 11 August 2026. doi:10.1111/dom.71184

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.